Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease

Hum Pathol. 2020 Mar:97:19-28. doi: 10.1016/j.humpath.2019.12.005. Epub 2020 Jan 7.

Abstract

Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal carcinoma. The significance of serrated lesions resembling traditional serrated adenoma (TSA) in IBD patients is unclear. In this retrospective study, we analyzed 52 TSA-like lesions arising in 30 IBD patients and diagnosed in colectomy or endoscopic specimens. The 27 colectomy lesions presented predominantly as ill-defined areas with granular appearance, with a median size of 15 mm, located throughout the large bowel and associated with synchronous advanced colorectal lesions in 58%. Low-grade serrated dysplasia was present in 56%, high-grade serrated dysplasia in 37%, and TSA-type cytology in 7%. Increased Ki-67 immunostaining and abnormal p53 expression were identified in 96% and 48%, respectively; 74% had a KRAS mutation, and 4% had a BRAF mutation. Endoscopically resectable TSA-like lesions were all discrete polypoid lesions, smaller in size (median 9 mm), predominantly in the distal large bowel, with an adjacent precursor polyp in 24%, and associated with synchronous and metachronous advanced colorectal lesions in 6%. Most (92%) show TSA-type cytology. p53 overexpression was present in 4%, KRAS mutation in 41%, and BRAF mutation in 32%. None of the 52 TSA-like lesions demonstrated loss of MLH1 or SATB2 expression by immunohistochemistry. On follow-up, 4 patients were diagnosed with colorectal carcinoma or high-grade adenomatous IBD-associated dysplasia. None of the patients with lesions showing TSA-type cytology only developed an advanced lesion. Our findings suggest that some TSA-like lesions, essentially from colectomy, may represent a form of IBD-associated dysplasia associated with an increased risk of advanced neoplasia.

Keywords: Crohn disease; Dysplasia; Inflammatory bowel disease; Serrated polyps; Traditional serrated adenoma; Ulcerative colitis.

MeSH terms

  • Adenomatous Polyps / chemistry
  • Adenomatous Polyps / genetics
  • Adenomatous Polyps / pathology*
  • Adenomatous Polyps / surgery
  • Adult
  • Aged
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / genetics
  • Carcinoma / chemistry
  • Carcinoma / genetics
  • Carcinoma / pathology*
  • Carcinoma / surgery
  • Colectomy
  • Colitis, Ulcerative / genetics
  • Colitis, Ulcerative / metabolism
  • Colitis, Ulcerative / pathology*
  • Colitis, Ulcerative / surgery
  • Colonic Polyps / chemistry
  • Colonic Polyps / genetics
  • Colonic Polyps / pathology*
  • Colonic Polyps / surgery
  • Colonoscopy
  • Colorectal Neoplasms / chemistry
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology*
  • Colorectal Neoplasms / surgery
  • Crohn Disease / genetics
  • Crohn Disease / metabolism
  • Crohn Disease / pathology*
  • Crohn Disease / surgery
  • Disease Progression
  • Female
  • Humans
  • Ki-67 Antigen / analysis
  • Male
  • Middle Aged
  • Mutation
  • Precancerous Conditions / genetics
  • Precancerous Conditions / metabolism
  • Precancerous Conditions / pathology*
  • Precancerous Conditions / surgery
  • Proto-Oncogene Proteins B-raf / genetics
  • Proto-Oncogene Proteins p21(ras) / genetics
  • Retrospective Studies
  • Treatment Outcome
  • Tumor Suppressor Protein p53 / analysis
  • Young Adult

Substances

  • Biomarkers, Tumor
  • KRAS protein, human
  • Ki-67 Antigen
  • MKI67 protein, human
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Proto-Oncogene Proteins p21(ras)